Development of a tumor-selective approach to treat metastatic cancer.
Patients diagnosed with metastatic cancer have almost uniformly poor prognoses. The treatments available for patients with disseminated disease are usually not curative and have side effects that limit the therapy that can be given. A treatment that is selectively toxic to tumors would maximize the...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2006-12-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC1762394?pdf=render |